U.S. Intravenous Immunoglobulin Market: Specialty Pharmacy Gains Ground

The U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a 7.7% CAGR from 2023 to 2030.